We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.

1erv

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:1erv.gif|left|200px]]
+
{{Seed}}
 +
[[Image:1erv.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1erv| PDB=1erv | SCENE= }}
{{STRUCTURE_1erv| PDB=1erv | SCENE= }}
-
'''HUMAN THIOREDOXIN MUTANT WITH CYS 73 REPLACED BY SER (REDUCED FORM)'''
+
===HUMAN THIOREDOXIN MUTANT WITH CYS 73 REPLACED BY SER (REDUCED FORM)===
-
==Overview==
+
<!--
-
BACKGROUND: Human thioredoxin reduces the disulfide bonds of numerous proteins in vitro, and can activate transcription factors such as NFkB in vivo. Thioredoxin can also act as a growth factor, and is overexpressed and secreted in certain tumor cells. RESULTS: Crystal structures were determined for reduced and oxidized wild type human thioredoxin (at 1.7 and 2.1 A nominal resolution, respectively), and for reduced mutant proteins Cys73--&gt;Ser and Cys32--&gt;Ser/Cys35--&gt;Ser (at 1.65 and 1.8 A, respectively). Surprisingly, thioredoxin is dimeric in all four structures; the dimer is linked through a disulfide bond between Cys73 of each monomer, except in Cys73--&gt;Ser where a hydrogen bond occurs. The thioredoxin active site is blocked by dimer formation. Conformational changes in the active site and dimer interface accompany oxidation of the active-site cysteines, Cys32 and Cys35. CONCLUSIONS: It has been suggested that a reduced pKa in the first cysteine (Cys32 in human thioredoxin) of the active-site sequence is important for modulation of the redox potential in thioredoxin. A hydrogen bond between the sulfhydryls of Cys32 and Cys35 may reduce the pKa of Cys32 and this pKa depression probably results in increased nucleophilicity of the Cys32 thiolate group. This nucleophilicity, in tum, is thought to be necessary for the role of thioredoxin in disulfide-bond reduction. The physiological role, if any, of thioredoxin dimer formation remains unknown. It is possible that dimerization may provide a mechanism for regulation of the protein, or a means of sensing oxidative stress.
+
The line below this paragraph, {{ABSTRACT_PUBMED_8805557}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 8805557 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_8805557}}
==About this Structure==
==About this Structure==
Line 30: Line 34:
[[Category: Thioredoxin]]
[[Category: Thioredoxin]]
[[Category: X-ray crystallography]]
[[Category: X-ray crystallography]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May 2 15:26:52 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 1 01:46:36 2008''

Revision as of 22:46, 30 June 2008

Image:1erv.png

Template:STRUCTURE 1erv

HUMAN THIOREDOXIN MUTANT WITH CYS 73 REPLACED BY SER (REDUCED FORM)

Template:ABSTRACT PUBMED 8805557

About this Structure

1ERV is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Crystal structures of reduced, oxidized, and mutated human thioredoxins: evidence for a regulatory homodimer., Weichsel A, Gasdaska JR, Powis G, Montfort WR, Structure. 1996 Jun 15;4(6):735-51. PMID:8805557

Page seeded by OCA on Tue Jul 1 01:46:36 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/1erv"
Personal tools